Consistently innovating.

As diligent in our studies and research as we are with our patients, the USDH Clinical Research team is constantly pushing the boundaries on what exceptional GI care can look like in the future. 

Conducting dozens of clinical trials, we are trusted by key stakeholders from academia, local community hospitals, Pharma, Medical Device, and Healthcare Informatics companies at our four research facilities to ensure the highest level of data integrity in each trial we perform. We pride ourselves on the quality of our work – our clinical research staff are all trained in Good Clinical Practice (GCP) and International Air Transport Association (IATA) shipping practices while receiving in-service training to ensure best practices are followed.

Beyond our platform for conducting Nonalcoholic Steatohepatitis (NASH) and Inflammatory Bowel Disease (IBD) trials, our network-wide integration of GI GeniusTM, the first AI-enabled colon cancer screening technology, has allowed our providers to provide patients with higher levels of medical precision than ever before. Innovative thinking and advancements like these have allowed us to become industry experts in real-world evidence studies, and cancer diagnostics research. It’s through our four dedicated research facilities that we will continue to be at the forefront of GI medicine, both now and the future. 

Please reach out to if you are interested in collaborating with USDH Clinical Research. 

Are you a referring doctor or referring provider?

If you’re looking to join the USDH network or become a provider with us, or are looking to refer your patient to one of our GI specialists, please select the appropriate link below to get started.